Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Droplet Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Droplet Biosciences

Droplet Biosciences

Seed

Droplet Biosciences: Pioneering in lymphatic fluid diagnostics for early, accurate cancer detection.

HQ
Melrose, MA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize cancer diagnostics, Droplet Biosciences focuses on utilizing lymphatic fluid for earlier and more accurate detection of cancer. The company envisions a future where lymphatic fluid diagnostics become a standard practice, offering a rich source of biomarkers for identifying cancer recurrence risks before metastasis occurs. Their innovative platform enables routine access to patient lymph fluid, which has historically been challenging to obtain for research or diagnostic purposes.

Droplet Biosciences has garnered attention from notable figures in the biotech industry and has attracted significant investment to advance its groundbreaking technology. The company has achieved key milestones in developing its platform, positioning itself as a leader in the emerging field of lymphatic fluid diagnostics. By providing a new avenue for early cancer detection, Droplet Biosciences is poised to make a substantial impact on patient outcomes and the broader healthcare landscape.

Droplet Biosciences - Similar Companies

Micronoma logo

Micronoma

micronoma.com

Torpedo Diagnostics logo

Torpedo Diagnostics

Salish Bioscience logo

Salish Bioscience

Foresight Diagnostics logo

Foresight Diagnostics

foresight-dx.com

BioFluidica logo

BioFluidica

biofluidica.com

Mercy BioAnalytics logo

Mercy BioAnalytics

mercybio.com

Liquid Genomics logo

Liquid Genomics

Exai Bio logo

Exai Bio

exai.bio

Liquid Biotech logo

Liquid Biotech

Thrive Earlier Detection logo

Thrive Earlier Detection

BloodQ logo

BloodQ

bloodq.com

CellDrop Biosciences logo

CellDrop Biosciences

celldrop.co

Pharus Diagnostics logo

Pharus Diagnostics

pharusdx.com

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

Lucence logo

Lucence

lucence.com

Droplet Biosciences - Quick Facts

Who are Droplet Biosciences' competitors?

Companies similar to Droplet Biosciences include Micronoma, Torpedo Diagnostics, Salish Bioscience and Foresight Diagnostics.

When was Droplet Biosciences founded?

Droplet Biosciences was founded in 2021.

Where is Droplet Biosciences' headquarters located?

Droplet Biosciences' headquarters is located in Melrose, MA, US.

When was Droplet Biosciences' last funding round?

Droplet Biosciences' most recent funding round was for $8M (USD) in March 2023.

How much has Droplet Biosciences raised to-date?

As of Mar 16, 2023, Droplet Biosciences has raised a total of $8M (USD).

How many employees does Droplet Biosciences have?

Droplet Biosciences has 30 employees as of Feb 5, 2024.

Droplet Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Detection
  • Diagnostics
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities